Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE

K-Number: K880199 · 1989-01-27

ApplicantSclavo, Inc.
Decision Date1989-01-27
Product CodeDIH
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE is the device name listed in this FDA 510(k) record. The listed applicant is Sclavo, Inc.. It received FDA 510(k) clearance on 1989-01-27 under 510(k) number K880199. The device is classified under product code DIH. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE?

CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE is a medical device that received FDA 510(k) clearance on 1989-01-27. The listed applicant is Sclavo, Inc.. The 510(k) number is K880199.

When did CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE receive FDA 510(k) clearance?

CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE received FDA 510(k) clearance on 1989-01-27, under 510(k) number K880199.

Who is the listed applicant for CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE?

The FDA 510(k) record lists Sclavo, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE?

The FDA product code for CHOLINESTERASE - ACETYTHIOCHOLINE SUBSTRATE is DIH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Sclavo, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K914789ELISA CMV IGMK914852ELISA TOXO IGMK914420ELISA RUBELLA IGMK895943NORMAL AND ABNORMAL CONTROL SERAK895822TOTAL BILIRUBIN L.F.K895847CREATININE 340 (ENZYMATIC)

View all 82 devices →

Related Devices (Code: DIH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K103373SYNCHRON SYSTEMS CHOLINESTERASE (CHEX) MODEL A53722Beckman Coulter, Inc.K061093CHOLINESTERASE GEN.2 TEST SYSTEMRoche Diagnostics Corp.K051444SENTINEL CHOLINESTERASE LIQUIDSentinel Ch. SrlK030045OLYMPUS CHOLINESTERASE REAGENT (CATALOG NUMBER OSR6114)Olympus America, Inc.K023992WIENER LAB COLINESTERASA AAWiener Laboratories SaicK013750ADVIA 1650 CHOLINESTERASE ASSAYBayer Diagnostics Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑